Psychopharmacological Agents (eBook)

Front Cover 
1 
Psychopharmacological Agents 4
Copyright Page 5
Table of Contents 16
Dedication 6
List of Contributors 8
Foreword 10
Preface to Volume I 12
Preface to Volume II 14
Contents of Volume I 19
Chapter 1. 
20 
I. INTRODUCTION 21
II. SYNTHESIS OF THE PHENOTHIAZINES 22
III. SOME PROCEDURES FOR THE PHARMACOLOGICAL EVALUATION OF PSYCHOPHARMACOLOGICAL AGENTS 52
IV. PHARMACOLOGY OF CHLORPROMAZINE 56
V. STRUCTURE-ACTIVITY RELATIONSHIPS IN THE PHENOTHIAZINES 138
VI. In Vivo DISTRIBUTION AND METABOLISM OF PHENOTHIAZINES 151
VII. ANALYTICAL METHODS FOR PHENOTHIAZINES 165
VIII. MISCELLANEOUS PROPERTIES OF PHENOTHIAZINES 169
IX. SUMMARY OF CLINICAL APPLICATIONS 169
REFERENCES 180
Chapter 2. 
218 
I. ORIGIN 218
II. STRUCTURE-ACTIVITY RELATIONSHIPS 225
III. PHARMACOLOGICAL ACTIVITY OF THE BUTYROPHENONES 228
IV. CLINICAL USES 236
REFERENCES 250
Chapter 3. 
268 
I. INTRODUCTION 268
II. THEORIES OF MENTAL DISEASE 270
REFERENCES 296
Chapter 4. Miscellaneous Psychotherapeutic Agents 302
Text 302
REFERENCES 319
Appendix A: Phenothiazine Bibliographies 322
A.1 Acetophenazine 324
A.2 Carphenazine 327
A.3 Fluphenazine 330
A.4 Mepazine 342
A.5 Methdilazone 349
A.6 Methoxypromazine 351
A.7 Perphenazine 354
A.8 Pipamazine 382
A.9 Prochlorperazine 384
A.10 Promazine 408
A.11 Propiomazine 425
A.12 Prothipendyl 427
A.13 Thiethylperazine 433
A.14 Thiopropazate 435
A.15 Thioridazine 440
A.16 Trifluoperazine 454
A.17 Triflupromazine 479
A.18 Trimeprazine 488
Appendix B: Meprobamate-like Agents Bibliographies 494
B.1 Phenaglycodol 496
B.2 Mephenoxalone 498
B.3 Promoxalone 500
B.4 Emylcamate 501
B.5 Hydroxyphenamate 502
B.6 Phenylpropanolcarbamate 503
B.7 Metaxalone 504
B.8 Methocarbamol 505
B.9 Oxanamide 509
B.10 Ectylurea 510
B.11 Methyprylone 511
B.12 Ethchlorvynol 516
Appendix C: Addenda to Volume I 518
C.1 Chlorprothixene 520
C.2 Clinical Applications of the Monoamine Oxidase Inhibitors (Hydrazines): Addendum 538
C.3 Biochemistry and Pharmacology of the Monoamine Oxidase Inhibitors (Hydrazines): Addendum 542
Author Index 552
Subject Index 594